BRÈVE

sur Frequency Exchange Corp. (isin : CA3580191078)

FREmedica Partners With CellCore at ECO24

Frequency Exchange Corp. announced that its subsidiary, FREmedica Technologies Inc., is among forty companies participating in the ECO24 event hosted by CellCore Biosciences. The event, primarily attended by 1,500 professionals, takes place from May 2-4 in Dallas, Texas. CellCore Biosciences is recognized for its expertise in digestive, immune, and mitochondrial health, spearheading the foundational medicine approach within the nutritional supplement sector with their Carbon Technology.

ECO24 aims to merge over 1,500 doctors, emphasizing education on innovative products and healing techniques, highly relevant for those proficient in Lyme and frequency-focused medicine. The event promises substantial clinical advancements through speeches by Dr. Todd Watts, Dr. Jay Davidson, and other specialists. An interactive, three-day agenda allows intensive learning, extended discussions, and networking among participants.

Dr. Drew Kidder from CellCore highlighted the inclusion of FREmedica’s NIKKI frequency delivery system at the event, which is pre-loaded with exclusive frequency sets for ECO24. Stephen Davis, CEO of Frequency Exchange, expressed gratitude towards Dr. Kidder for the collaboration opportunity, noting that NIKKI will serve as a practical demonstration for attendees, reinforcing the utility of frequency medicine in modern healthcare practices.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Frequency Exchange Corp.